AMY L. BARRACLOUGH PA-C
Prescription History 1770533713
Physician Assistant in Portland, ME
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for AMY L. BARRACLOUGH PA-C, an active Physician Assistant specialist practicing in Portland, ME. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 245 documented patient claims. Among these therapy options, the most frequently utilized medication is Paxlovid (Eua), which accounts for 143 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other ME PrescribersVs. ME Avg |
|---|---|---|---|
| Paxlovid (Eua)Nirmatrelvir/Ritonavir | 143 | $9.87▼ below ME avg | ▲ More than typical |
About Paxlovid (Eua): The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾ The product is also approved to be used in Canada to treat COVID-19. It is used by people who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with nirmatrelvir and ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases (boosts) the levels of nirmatrelvir. This helps nirmatrelvir work better. More information about nirmatrelvir and ritonavir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use and from the Health Canada Patient Medication Information sheet. There is limited information about how safe and effective the combination of nirmatrelvir and ritonavir is for treating COVID-19. Study results show that nirmatrelvir and ritonavir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of nirmatrelvir and ritonavir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions. In 2023, this provider wrote 143 Medicare prescriptions for Paxlovid (Eua), about 7.2 times the volume of the typical Maine prescriber of this medication (20). Medicare paid an average of $9.87 per fill, versus $10.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 143 30-Day Fills standardized to 30-day supplies 715 Days of Medication total across all patients in 2023 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $16.92 | ▲ More than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate. In 2023, this provider wrote 24 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 1.3 times the volume of the typical Maine prescriber of this medication (18). Medicare paid an average of $16.92 per fill, versus $16.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 186 Days of Medication total across all patients in 2023 | |||
| Cephalexin | 19 | $8.79▼ below ME avg | ≈ Typical |
About Cephalexin: This medication is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. In 2023, this provider wrote 19 Medicare prescriptions for Cephalexin, about 86% of the volume of the typical Maine prescriber of this medication (22). Medicare paid an average of $8.79 per fill, versus $9.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 19 30-Day Fills standardized to 30-day supplies 123 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $4.24▼ below ME avg | ≈ Typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 18 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about the same volume as the typical Maine prescriber of this medication (20). Medicare paid an average of $4.24 per fill, versus $5.88 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 18 30-Day Fills standardized to 30-day supplies 87 Days of Medication total across all patients in 2023 | |||
| Prednisone | 15 | $2.88▼ below ME avg | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 15 Medicare prescriptions for Prednisone, about a third of the volume of the typical Maine prescriber of this medication (40). Medicare paid an average of $2.88 per fill, versus $6.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 15 30-Day Fills standardized to 30-day supplies 105 Days of Medication total across all patients in 2023 | |||
| Doxycycline Monohydrate | 13 | $17.88▼ below ME avg | ▼ Less than typical |
About Doxycycline Monohydrate: This medication is used to treat a certain type of skin condition called rosacea. Show more ▾ It helps to reduce the number of pimples and bumps on the face, but it may not decrease redness. It works by reducing skin inflammation caused by rosacea. Although doxycycline belongs to the class of antibiotics known as tetracyclines, this product does not work as an antibiotic because it does not stop the growth of bacteria. Do not use this product to treat any infection, including viral infections (such as the common cold, flu). Use this medication only as prescribed by your doctor. A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE. In 2023, this provider wrote 13 Medicare prescriptions for Doxycycline Monohydrate, about 62% of the volume of the typical Maine prescriber of this medication (21). Medicare paid an average of $17.88 per fill, versus $21.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 13 30-Day Fills standardized to 30-day supplies 97 Days of Medication total across all patients in 2023 | |||
| Lagevrio (Eua)Molnupiravir | 13 | $10.12 | ▼ Less than typical |
About Lagevrio (Eua): Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾ It is used by adults 18 years of age and older who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with molnupiravir. Molnupiravir works by preventing the growth of the virus that causes COVID-19. More information about molnupiravir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use. There is limited information about how safe and effective molnupiravir is for treating COVID-19. Study results show that molnupiravir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of molnupiravir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions. In 2023, this provider wrote 13 Medicare prescriptions for Lagevrio (Eua), about 72% of the volume of the typical Maine prescriber of this medication (18). Medicare paid an average of $10.12 per fill, versus $10.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 65 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for AMY L. BARRACLOUGH PA-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Portland, ME practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among ME prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
